Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Neal

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Journal of Child Neurology|March 23, 2006
Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trialJames J Collins, Cynthia Tudor, Jennifer M Leonard, et al.
Digital Health|January 26, 2023
Read and accepted? Scoping the cognitive accessibility of privacy policies of health apps and websites in three European countriesDavid Neal, Sophie Gaber, Phil Joddrell, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 13, 2013
Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?Gert Wiegand, Theodor W May, Philipp Ostertag, et al.
Pediatric Neurology|September 21, 2024
Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate TreatmentLena-Luise Becker, Karen Agricola, David M Ritter, et al.
European Urology|April 17, 2007
Reducing warm ischaemia time during laparoscopic partial nephrectomy: a prospective comparison of two renal closure techniquesHervé Baumert, Andrew Ballaro, Nimish Shah, et al.
Journal of Health Services Research & Policy|November 5, 2003
Including a 'no active intervention' arm in surgical trials is possible: evidence from the CLasP randomised trialSara Brookes, Tim Peters, Rona Campbell, et al.
Neurology|January 18, 2013
Everolimus long-term safety and efficacy in subependymal giant cell astrocytomaDarcy A Krueger, Marguerite M Care, Karen Agricola, et al.
Journal of Orthopaedics|September 14, 2019
Comparison of Pavlik Harness treatment regimens for reduced but dislocatable (Barlow positive) hips in infantile DDHDavid Neal, Terri Beckwith, Adam Hines, et al.
Pediatric Neurology|May 20, 2025
Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous SclerosisLena-Luise Becker, Karen Agricola, David M Ritter, et al.
Journal of Clinical Medicine|February 10, 2021
Can Use of Digital Technologies by People with Dementia Improve Self-Management and Social Participation? A Systematic Review of Effect StudiesDavid Neal, Floor van den Berg, Caroline Planting, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Journal of Child Neurology|March 23, 2006
Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trialJames J Collins, Cynthia Tudor, Jennifer M Leonard, et al.
Digital Health|January 26, 2023
Read and accepted? Scoping the cognitive accessibility of privacy policies of health apps and websites in three European countriesDavid Neal, Sophie Gaber, Phil Joddrell, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 13, 2013
Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?Gert Wiegand, Theodor W May, Philipp Ostertag, et al.
Pediatric Neurology|September 21, 2024
Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate TreatmentLena-Luise Becker, Karen Agricola, David M Ritter, et al.
European Urology|April 17, 2007
Reducing warm ischaemia time during laparoscopic partial nephrectomy: a prospective comparison of two renal closure techniquesHervé Baumert, Andrew Ballaro, Nimish Shah, et al.
Journal of Health Services Research & Policy|November 5, 2003
Including a 'no active intervention' arm in surgical trials is possible: evidence from the CLasP randomised trialSara Brookes, Tim Peters, Rona Campbell, et al.
Neurology|January 18, 2013
Everolimus long-term safety and efficacy in subependymal giant cell astrocytomaDarcy A Krueger, Marguerite M Care, Karen Agricola, et al.
Journal of Orthopaedics|September 14, 2019
Comparison of Pavlik Harness treatment regimens for reduced but dislocatable (Barlow positive) hips in infantile DDHDavid Neal, Terri Beckwith, Adam Hines, et al.
Pediatric Neurology|May 20, 2025
Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous SclerosisLena-Luise Becker, Karen Agricola, David M Ritter, et al.
Journal of Clinical Medicine|February 10, 2021
Can Use of Digital Technologies by People with Dementia Improve Self-Management and Social Participation? A Systematic Review of Effect StudiesDavid Neal, Floor van den Berg, Caroline Planting, et al.
Pageof 13